Work

Employing Integrated Omics, Artificial Intelligence and Machine learning Tools for Refined Stratification of Blast Crisis CML Patients via Genetic clustering and COSMIC Mutational Signatures: A Practical Framework for Precision Repurposing of FDA/EMA-Approved Anti-Cancer Drugs in Refractory Cancers post-COVID19

Year: 2025

Type: preprint

Study design: Observational Study

Source: SSRN Electronic Journal

DOI: 10.2139/ssrn.5364191

Authors: Dr. Zafar Iqbal, Abdulkareem Algarni, Nawaf Alanzazi, Sarah AlMukhaylid, Sultan Al Qahtani, Masood Shammas, Hussain Alrowaily, Abdulaziz Siyal, Rizwan Naeem, Yaqob Taleb, Aamer Aleem, Amer Mahmood

Institutions: King Abdulaziz Hospital, King Abdulaziz Hospital, King Saud bin Abdulaziz University for Health Sciences, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Northern Border University, King Saud University, Albert Einstein College of Medicine, King Abdulaziz Medical City, National Guard Health Affairs

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4412627085

Cites:

Cited by:

Related to: 10